Keywords: جهش EGFR; EGFR mutations; Microfluidic paper-based electrochemical DNA biosensor; Saliva;
مقالات ISI جهش EGFR (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: جهش EGFR; Lung cancer; Hispanic; EGFR mutations; Ancestry;
Keywords: جهش EGFR; Telomere; Non-small cell lung cancer; Cancer risk; Polymorphism; EGFR mutations
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
Keywords: جهش EGFR; Non-small cell lung carcinoma (NSCLC); EGFR mutations; Fine needle aspiration (FNA) biopsy; Targeted therapy; PD-L1 immunotherapy;
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC
Keywords: جهش EGFR; Advanced non-small cell lung cancer; EGFR mutations; liquid biopsy; osimertinib;
Diagnosis of EGFR exon21 L858R point mutation as lung cancer biomarker by electrochemical DNA biosensor based on reduced graphene oxide /functionalized ordered mesoporous carbon/Ni-oxytetracycline metallopolymer nanoparticles modified pencil graphite elec
Keywords: جهش EGFR; Cancer biomarker; EGFR mutations; Metallopolymer nanoparticles;
ReviewUncommon EGFR mutations in advanced non-small cell lung cancer
Keywords: جهش EGFR; NSCLC; Uncommon; EGFR mutations; Tyrosine kinase inhibitors;
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going
Keywords: جهش EGFR; NSCLC; EGFR mutations; Osimertinib; Olmutinib; Rociletinib; Afatinib; EGFR TKI; Resistance;
Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry
Keywords: جهش EGFR; ALK gene rearrangements; EGFR mutations; Lung cancer; Never smoker; Passive smoking;
Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
Keywords: جهش EGFR; BRAF mutations; V600E mutation; Lung cancer; EGFR mutations; Smoking
Detection of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma: Comparing Cobas 4800 EGFR Assay With Sanger Bidirectional Sequencing
Keywords: جهش EGFR; Cobas assay; EGFR mutations; Lung adenocarcinoma; Sanger sequencing; Tyrosine kinase inhibitor;
Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib
Keywords: جهش EGFR; Lung cancer; non-small cell; EGFR mutations; tyrosine kinase inhibitors; tumor volume;
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
Keywords: جهش EGFR; Urine; Circulating tumor DNA; NSCLC; EGFR mutations; T790M;
Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations
Keywords: جهش EGFR; NSCLC; Erlotinib; EGFR mutations; Uncommon; Rare;
EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect
Keywords: جهش EGFR; ALK rearrangements; Crizotinib; EGFR mutations; Erlotinib; KRAS mutations;
Cross-reactivity of EGFR L858R mutation-specific antibody in HER2 positive gastric adenocarcinomas
Keywords: جهش EGFR; EGFR mutations; L858R; HER2; Metastatic cancer; Lung cancerMutaciones de EGFR; L858R; HER2; Cáncer metastásico; Cáncer de pulmón
Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study
Keywords: جهش EGFR; Targeted therapy; INSIGHT; EGFR mutations; Molecular analysis;
EGFR mutation testing in pulmonary adenocarcinoma: Evaluation of tumor cell number and tumor percent in paraffin sections of 120 small biopsies
Keywords: جهش EGFR; EGFR mutations; Lung tumors; Tumor cell numbers; Needle-biopsy; Bronchial biopsy
The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer
Keywords: جهش EGFR; EGFR mutations; EGFR-tyrosine kinase inhibitors; Adenocarcinoma lung cancer; Deletion exon 19; L858R mutation;
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
Keywords: جهش EGFR; Lung cancer; Adenocarcinoma; Epidermal growth factor receptor; EGFR mutations; Tyrosine kinase inhibitor
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients
Keywords: جهش EGFR; EGFR mutations; NSCLC; Plasma; Next-generation sequencing; Predictive medicine;
Significance of EGFR signaling pathway genetic alterations in radically resected non-small cell lung cancers from a Polish cohort. One institutional study
Keywords: جهش EGFR; NSCLC; Gene copy gain; EGFR mutations; KRAS mutations
Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression
Keywords: جهش EGFR; Vorinostat; Erlotinib; NSCLC; EGFR mutations; Histone deacetylase inhibitors; TKIs resistance
Novel EGFR mutation-specific antibodies for lung adenocarcinoma: Highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry
Keywords: جهش EGFR; Lung adenocarcinoma; EGFR mutations; Mutation-specific antibody; E746_A750 deletion; L858R mutation; Immunohistochemistry
Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma
Keywords: جهش EGFR; EGFR mutations; Heterogeneity; Mixed type adenocarcinoma; Non-small-cell lung cancer; Smoking;
Results of the First Italian External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non–Small-Cell Lung Cancer
Keywords: جهش EGFR; Non–small-cell lung carcinoma; EGFR mutations; Quality assessment
Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy
Keywords: جهش EGFR; Non-small-cell lung cancer; Early progressive disease; Refractory patients; Platinum-based chemotherapy; Sarcomatoid carcinoma; EGFR mutations; KRAS mutations; ALK translocation
Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma in Malaysian Patients
Keywords: جهش EGFR; EGFR mutations; Lung adenocarcinoma; Malaysian
Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance
Keywords: جهش EGFR; EGFR; NSCLC; EGFR mutations; Tyrosine kinase inhibitors; Uncommon EGFR mutations; EGFR TKI sensitivity
Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer—Its implication in mutagenesis of non-small cell lung carcinoma
Keywords: جهش EGFR; CYP2A13; Early occurrence; Lung cancer; NSCLC; EGFR mutations; IHC
Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma
Keywords: جهش EGFR; EGFR mutations; Secondary resistance; Gefitinib; Erlotinib; Afatinib; Dacomitinib; Tyrosine kinase inhibitors; Non-small-cell lung cancer
Direct Comparison of 3 PCR Methods in Detecting EGFR Mutations in Patients with Advanced Non–Small-Cell Lung Cancer
Keywords: جهش EGFR; EGFR mutations; Mutant-enriched PCR; Non–small-cell lung cancer; PCR invader; Peptide nucleic acid-locked nucleic acid (PNA-LNA) PCR clamp
EGFR-Mutant Lung Adenocarcinomas Treated First-Line with the Novel EGFR Inhibitor, XL647, Can Subsequently Retain Moderate Sensitivity to Erlotinib
Keywords: جهش EGFR; Non-small cell lung cancer; EGFR mutations; XL647; EGFR tyrosine kinase inhibitors; Acquired resistance; Gefitinib; Erlotinib; Afatinib
EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery
Keywords: جهش EGFR; Lung cancer; EGFR mutations; Frequency; Caucasian
Recherche des altérations d'EGFR : avancées des pratiques
Keywords: جهش EGFR; Mutations d'EGFR; Plateformes; Biologie moléculaire; PCR; Séquençage; EGFR mutations; Platforms; Molecular biology; Sequencing; PCR;
Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for th
Keywords: جهش EGFR; Non-small cell lung cancer; EGFR mutations; KRAS mutations
Correlation between Epidermal Growth Factor Receptor Mutations and Expression of Female Hormone Receptors in East-Asian Lung Adenocarcinomas
Keywords: جهش EGFR; Hormone receptors; EGFR mutations; Prognosis; Adenocarcinoma; Females
Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival
Keywords: جهش EGFR; EGFR mutations; Bone metastasis; Lung cancer; Tyrosine kinase inhibitors; Osteoblastic reaction
Association of Epidermal Growth Factor Receptor Activating Mutations with Low ERCC1 Gene Expression in Non-small Cell Lung Cancer
Keywords: جهش EGFR; EGFR mutations; ERCC1 expression
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
Keywords: جهش EGFR; NSCLC; K-RAS mutations; Front-line chemotherapy; EGFR mutations; TKIs
Biomarkers in lung oncology
Keywords: جهش EGFR; Non-small-cell lung cancer; BRCA1; EGFR mutations; Customized chemotherapy
Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients
Keywords: جهش EGFR; Gefitinib; Non-small cell lung cancer (NSCLC); EGFR tyrosine kinase inhibitor (TKI); EGFR mutations
NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan
Keywords: جهش EGFR; Lung cancer; EGFR mutations; NAT2 polymorphisms;
Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)
Keywords: جهش EGFR; Non-small cell lung cancer; Advanced stage; Early stage; Whole genome amplification; Low-volume biopsies; KRAS mutations; CMET mutations; EGFR mutations; p53 mutations; Prognosis
Epidermal Growth Factor Receptor-Related Tumor Markers and Clinical Outcomes with Erlotinib in Non-small Cell Lung Cancer: An Analysis of Patients from German Centers in the TRUST Study
Keywords: جهش EGFR; Erlotinib; Non-small cell lung cancer; Epidermal growth factor receptor (EGFR); EGFR mutations; EGFR gene copy number
A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells
Keywords: جهش EGFR; Cytologic samples; EGFR mutations; erlotinib; Non-small cell lung cancer; T790M
The Prognostic Value of Chromosome 7 Polysomy in Non-small Cell Lung Cancer Patients Treated with Gefitinib
Keywords: جهش EGFR; Non-small cell; Targeted therapy; Molecular biomarkers; Aneusomy; EGFR mutations
Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation
Keywords: جهش EGFR; Epidermal growth factor receptor; EGFR mutations; Bronchioloalveolar carcinoma; Gefitinib;
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer
Keywords: جهش EGFR; EGFR mutations; Gefitinib; Non-small-cell lung cancer;